Cited by 1,200Dermatology and Skin DiseasesReliability and Agreement in MeasurementContact Dermatitis and Allergies

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., Evaluator Group, The Easi·2001·Experimental Dermatology

DOI 10.1034/j.1600-0625.2001.100102.x

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. DESIGN: Training of evaluators, application, and assessment over 2 consecutive days. SETTING: An academic center. PATIENTS: Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients > or = 8 years) and cohort 2 (10 patients < 8 years). INTERVENTIONS: None. MAIN OUTCOME MEASURE: The EASI was used by 15 dermatologist evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. RESULTS: Overall intra-evaluator reliability of the EASI was in the fair-to-good range. Inter-evaluator reliability analyses indicated that the evaluators assessed the patients consistently across both study days. CONCLUSIONS: This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.

Integrity signals

Registry

Crossref · 10.1034/j.1600-0625.2001.100102.x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Self-citation
The Design and Analysis of Clinical Experiments
Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,304
Large sample standard errors of kappa and weighted kappa.
Fleiss, J. L., Cohen, J., & Everitt, B. S. (1969) · Psychological Bulletin · doi:10.1037/h0028106 · Cited by 1,536
Grading of the severity of atopic dermatitis.
Rajka, G., & Langeland, T. (1989) · PubMed · doi:10.2340/000155551441314 · Cited by 415
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis
Sowden, J. M., Allen, B. R., Berth‐Jones, J., GRAHAM-BROWN, R. A. C., Motley, R., Finlay, A. Y., Salek, S., Marks, R., Ross, J., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children
Kang, S., Lucky, A. W., Pariser, D. M., Lawrence, I., & Hanifin, J. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109812 · Cited by 329
Self-citation
A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients
Paller, A. S., Eichenfield, L. F., Leung, D. Y. M., Stewart, D., & Appell, M. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109813 · Cited by 323
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy
Hanifin, J. M., LING, M. R., Langley, R. G. B., Breneman, D., & Rafal, E. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109810 · Cited by 285
Self-citation

Show all 17 references

Research works printed but not linked: 1

Fleiss J L, 1986, New York., 1

Sorted by citations

Items 101–200 of 1,000

Interventions to reduce Staphylococcus aureus in the management of atopic eczema
Birnie, A. J., Bath-Hextall, F. J., Ravenscroft, J., & Williams, H. C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003871.pub2 · Cited by 127
Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients
Jakasa, I., Verberk, M. M., Esposito, M., Bos, J. D., & Kezic, S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700582 · Cited by 124
Systemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis
Siegels, D., Heratizadeh, A., Abraham, S., Binnmyr, J., Brockow, K., Irvine, A. D., Halken, S., Mortz, C. G., Flohr, C., Schmid‐Grendelmeier, P., et al. (2020) · Allergy · doi:10.1111/all.14631 · Cited by 124
Contagious itch in humans: a study of visual ‘transmission’ of itch in atopic dermatitis and healthy subjects
Papoiu, A. D. P., Wang, H., Coghill, R. C., Chan, Y., & Yosipovitch, G. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10318.x · Cited by 123
Skin care interventions in infants for preventing eczema and food allergy
Kelleher, M. M., Cro, S., Cornelius, V. R., Carlsen, K. C. L., Skjerven, H. O., Rehbinder, E. M., Lowe, A. J., Dissanayake, E., Shimojo, N., Yonezawa, K., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013534.pub2 · Cited by 123
Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study
Nakagawa, H., Nemoto, O., Igarashi, A., Saeki, H., Kabashima, K., Oda, M., & Nagata, T. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.06.014 · Cited by 119
Ceramide profiles of the uninvolved skin in atopic dermatitis and psoriasis are comparable to those of healthy skin
Farwanah, H., Raith, K., Neubert, R. H. H., & Wohlrab, J. (2005) · Archives of Dermatological Research · doi:10.1007/s00403-005-0551-2 · Cited by 123
Long‐term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis
Luger, T., Lahfa, M., Fölster‐Holst, R., Gulliver, W., Allen, R., Molloy, S., Barbier, N., Paul, C. F., & Bos, J. D. (2004) · Journal of Dermatological Treatment · doi:10.1080/09546630410033781 · Cited by 119
Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study
Saeki, H., Kabashima, K., TOKURA, Y., Murata, Y., Shiraishi, A., Tamamura, R., Randazzo, B. P., & Imanaka, K. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15493 · Cited by 116
Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: A two-year study
Papp, K. A., Werfel, T., Fölster‐Holst, R., Ortonne, J. P., Potter, P. C., Prost, Y. D., Davidson, M. J., Barbier, N., Goertz, H., & Paul, C. F. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.09.016 · Cited by 114
The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument
Evers, A. W. M., Duller, P., van de Kerkhof, P. C. M., van der Valk, P. G. M., de Jong, E. M. G. J., Gerritsen, M., Otero, E., Verhoeven, E. W. M., Verhaak, C. M., & Kraaimaat, F. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08296.x · Cited by 113
The European treatment of severe atopic eczema in children taskforce (TREAT) survey
Proudfoot, L. E., Powell, A. M., Ayis, S. A., Barbarot, S., Baselga, E., Deleuran, M. S., Fölster‐Holst, R., Gelmetti, C., Hernández‐Martín, A., Middelkamp-Hup, M. A., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12505 · Cited by 112
Epigallocatechin gallate/L-ascorbic acid–loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis
Chiu, Y.-H., Wu, Y., Hung, J.-I., & Chen, M. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.032 · Cited by 111
The Urban Environment and Childhood Asthma (URECA) birth cohort study: design, methods, and study population
Gern, J. E., Visness, C. M., Gergen, P. J., Wood, R. A., Bloomberg, G. R., O’Connor, G. T., Kattan, M., Sampson, H. A., Witter, F. R., Sandel, M. T., et al. (2009) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-9-17 · Cited by 111
Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME)
Chalmers, J. R., Schmitt, J. M., Apfelbacher, C., Dohil, M. A., Eichenfield, L. F., Simpson, E. L., Singh, J. A., Spuls, P. I., Thomas, K. S., Admani, S., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13237 · Cited by 110
Self-citation
Health‐related quality of life in patients with atopic dermatitis
Maksimović, N., Janković, S., Marinković, J., Sekulović, L. K., Živković, Z., & Tomić-Spirić, V. (2011) · The Journal of Dermatology · doi:10.1111/j.1346-8138.2011.01295.x · Cited by 110
Clinical differences between atopic and atopiform dermatitis
Brenninkmeijer, E. E. A., Spuls, P. I., Legierse, C. M., Lindeboom, R., Smitt, J. H. S., & Bos, J. D. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.12.002 · Cited by 110
Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis
Mack, M. R., Brestoff, J. R., Berrien-Elliott, M. M., Trier, A. M., Yang, T.-L. B., McCullen, M. V. D., Collins, P. L., Niu, H., Bodet, N. D., Wagner, J. A., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay1005 · Cited by 109
Phase 2 clinical study of delgocitinib ointment in pediatric patients with atopic dermatitis
Nakagawa, H., Nemoto, O., Igarashi, A., Saeki, H., Oda, M., Kabashima, K., & Nagata, T. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.08.004 · Cited by 107
OPA-15406, a novel, topical, nonsteroidal, selective phosphodiesterase-4 (PDE4) inhibitor, in the treatment of adult and adolescent patients with mild to moderate atopic dermatitis (AD): A phase-II randomized, double-blind, placebo-controlled study
Hanifin, J. M., Ellis, C. N., Frieden, I. J., Fölster-Holst, R., Stein Gold, L. F., Secci, A., Smith, A. J., Zhao, C., Kornyeyeva, E., & Eichenfield, L. F. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.001 · Cited by 106
Self-citation
Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
Nakagawa, H., Nemoto, O., Igarashi, A., Saeki, H., Murata, R., Kaino, H., & Nagata, T. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15173 · Cited by 105
Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients
Allen, B. R. (2003) · Archives of Disease in Childhood · doi:10.1136/adc.88.11.969 · Cited by 105
Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis
Benedetto, A. D., Slifka, M. K., Rafaels, N. M., Kuo, I., Georas, S. N., Boguniewicz, M., Hata, T. R., Schneider, L. C., Hanifin, J. M., Gallo, R. L., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.014 · Cited by 104
Self-citation
Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment
Simon, D., Vassina, E. M., Yousefi, S., Kozlowski, E., Braathen, L. R., & Simon, H. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.05.066 · Cited by 103
Treatment of atopic dermatitis with dupilumab: experience from a tertiary referral centre
Olesen, C. M., Holm, J. G., Nørreslet, L. B., Serup, J. V., Thomsen, S. F., & Agner, T. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.15609 · Cited by 102
Serum IgE Autoantibodies Target Keratinocytes in Patients with Atopic Dermatitis
Altrichter, S., Kriehuber, E., Moser, J., Valenta, R., Kopp, T., & Stingl, G. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.80 · Cited by 99
Cowhage-Induced Itch as an Experimental Model for Pruritus. A Comparative Study with Histamine-Induced Itch
Papoiu, A. D. P., Tey, H. L., Coghill, R. C., Wang, H., & Yosipovitch, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017786 · Cited by 99
The role of topical calcineurin inhibitors in atopic dermatitis:
Alomar, A., Berth‐Jones, J., Bos, J. D., Giannetti, A., Reitamo, S., Ruzicka, T., Stalder, J.-F., Thestrup‐Pedersen, K., & (EUROPEAN WORKING GROUP ON ATOPIC DERMATITIS) (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06269.x · Cited by 99
Warm, Humid, and High Sun Exposure Climates Are Associated with Poorly Controlled Eczema: PEER (Pediatric Eczema Elective Registry) Cohort, 2004–2012
Sargen, M. R., Hoffstad, O., & Margolis, D. J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.274 · Cited by 99
Skin Barrier Function in Healthy Subjects and Patients with Atopic Dermatitis in Relation to Filaggrin Loss-of-Function Mutations
Jakaša, I., Koster, E. S., Calkoen, F., McLean, W. H. I., Campbell, L. E., Bos, J. D., Verberk, M. M., & Kežić, S. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.307 · Cited by 98
Long-Term Efficacy and Safety of Pimecrolimus Cream 1% in Adults with Moderate Atopic Dermatitis
Meurer, M., Fartasch, M., Albrecht, G., VOGT, T. M., Worm, M., Ruzicka, T., Altmeyer, P. J., Schneider, D. M., Weidinger, G., & Braeutigam, M. (2004) · Dermatology · doi:10.1159/000078462 · Cited by 97
Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in M alaysia
Wong, S., Ng, T. G., & Baba, R. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12265 · Cited by 96
Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis
Bieber, T. R. M., Vick, K., Fölster‐Holst, R., Fortina, A. B., Städtler, G., Worm, M., & Arcangeli, F. (2007) · Allergy · doi:10.1111/j.1398-9995.2006.01269.x · Cited by 96
Effect of Itch, Scratching and Mental Stress on Autonomic Nervous System Function in Atopic Dermatitis
Yosipovitch, G., Tran, B. W., Papoiu, A. D. P., Russoniello, C., Wang, H., Patel, T., & Chan, Y. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0890 · Cited by 95
Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial
Goujon, C., Viguier, M. A., Staumont-Sallé, D., Bernier, C., Guillet, G., Lahfa, M., le Bouëdec, M.-C. F., Cambazard, F., Bottigioli, D., Grande, S., et al. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2017.07.007 · Cited by 95
Severe Chronic Allergic (and Related) Diseases: A Uniform Approach – A MeDALL – GA2LEN – ARIA Position Paper
In collaboration with the WHO Collaborating Center for Asthma and Rhinitis (2012) · International Archives of Allergy and Immunology · doi:10.1159/000332924 · Cited by 95
Drug Evaluation Review: Dupilumab in Atopic Dermatitis
Hamilton, J. D., Ungar, B., & Guttman‐Yassky, E. (2015) · Immunotherapy · doi:10.2217/imt.15.69 · Cited by 94
Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
Fargnoli, M. C., Esposito, M., Ferrucci, S. M., Girolomoni, G., Offidani, A., Patrizi, A., Peris, K., Costanzo, A., Malara, G., Pellacani, G., et al. (2019) · Journal of Dermatological Treatment · doi:10.1080/09546634.2019.1682503 · Cited by 94
Automatic detection and severity measurement of eczema using image processing
Alam, M. N., Munia, T. T. K., Tavakolian, K., Vasefi, F., MacKinnon, N. B., & Fazel-Rezai, R. (2016) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2016.7590961 · Cited by 93
Effectiveness of dupilumab treatment in 95 patients with atopic dermatitis: daily practice data
de Wijs, L. E. M., Bosma, A. L., Erler, N. S., Hollestein, L. M., Gerbens, L. A. A., Middelkamp-Hup, M. A., Kunkeler, A. C. M., Nijsten, T. E. C., Spuls, P. I., & Hijnen, D. (2019) · British Journal of Dermatology · doi:10.1111/bjd.18179 · Cited by 93
Use of the Self-Administered Eczema Area and Severity Index by parent caregivers: results of a validation study
Housman, T. S., Patel, M., Camacho, F., Feldman, S. R., Fleischer, A. B., & Balkrishnan, R. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.05031.x · Cited by 93
Critical Role for Mast Cell Stat5 Activity in Skin Inflammation
Ando, T., Xiao, W., Gao, P., Namiranian, S., Matsumoto, K., Tomimori, Y., Hong, H., Yamashita, H., Kimura, M., Kashiwakura, J. I., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.029 · Cited by 93
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial: WBI-1001 as a novel topical treatment for atopic dermatitis
Bissonnette, R., Poulin, Y., Zhou, Y., Tan, J., Hong, H. C., Webster, J., Ip, W., Tang, L., & Lyle, M. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10775.x · Cited by 92
Efalizumab for severe atopic dermatitis: A pilot study in adults
Takiguchi, R. H., Tofte, S. J., Simpson, B., Harper, E., Blauvelt, A., Hanifin, J. M., & Simpson, E. L. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.031 · Cited by 92
Self-citation
Effectiveness of a Multidisciplinary Itch-coping Training Programme in Adults with Atopic Dermatitis
Evers, A. W. M., Duller, P., de Jong, E. M. G. J., Otero, M., Verhaak, C. M., van der Valk, P. G. M., Kerkhof, P., & Kraaimaat, F. (2009) · Acta Dermato Venereologica · doi:10.2340/00015555-0556 · Cited by 92
Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
Ariëns, L. F. M., van der Schaft, J., Spekhorst, L. S., Bakker, D. S., Romeijn, G. L. E., Kouwenhoven, T. A., Kamsteeg, M., Voorberg, A. N., Oosting, A. J., de Ridder, I., et al. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.08.127 · Cited by 91
Oral H1 antihistamines as ‘add-on’ therapy to topical treatment for eczema
Matterne, U., Böhmer, M. M., Weißhaar, E., Jupiter, A., Carter, B., & Apfelbacher, C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012167.pub2 · Cited by 89
Efficacy and safety of PAC ‐14028 cream – a novel, topical, nonsteroidal, selective TRPV 1 antagonist in patients with mild‐to‐moderate atopic dermatitis: a phase II b randomized trial
Lee, Y. W., Won, C. H., Jung, K.-M., Nam, H. ‐., Choi, G., Park, Y. ‐., Park, M., & Kim, B. J. (2019) · British Journal of Dermatology · doi:10.1111/bjd.17455 · Cited by 89
Atopic Dermatitis
Leung, A. K. C., Hon, K. E., & Robson, W. L. M. (2007) · Advances in Pediatrics · doi:10.1016/j.yapd.2007.03.013 · Cited by 90
Dietary Elimination for the Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
Oykhman, P., Dookie, J., Al-Rammahy, H., Benedetto, A. D., Asiniwasis, R. N., LeBovidge, J., Wang, J., Ong, P. Y., Lio, P., Gutierrez, A., et al. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2022.06.044 · Cited by 89
Sleep disturbance in children with moderate/severe atopic dermatitis: A case-control study
Fishbein, A. B., Mueller, K. A., Kruse, L. L., Boor, P., Sheldon, S. H., Zee, P. C., & Paller, A. S. (2017) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.08.043 · Cited by 87
A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids
Murrell, D. F., Calvieri, S., Ortonne, J. ‐., Ho, V. C., Weise-Riccardi, S., Barbier, N., & Paul, C. F. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08192.x · Cited by 87
Consensus guidelines in diagnosis and treatment of atopic dermatitis
Eichenfield, L. F. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00569.x · Cited by 87
The efficacy of pulsed dye laser treatment for inflammatory skin diseases: A systematic review
Erceg, A., de Jong, E. M. G. J., van de Kerkhof, P. C. M., & Seyger, M. M. B. (2013) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.03.029 · Cited by 86
Burden of Atopic Dermatitis in the United States: Analysis of Healthcare Claims Data in the Commercial, Medicare, and Medi-Cal Databases
Shrestha, S., Miao, R., Wang, L., Chao, J., Yüce, H., & Wei, W. (2017) · Advances in Therapy · doi:10.1007/s12325-017-0582-z · Cited by 86
Etanercept is minimally effective in 2 children with atopic dermatitis
Buka, R. L., Resh, B., Roberts, B. J., Cunningham, B. B., & Friedlander, S. F. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.03.013 · Cited by 85
Skin biomarkers predict development of atopic dermatitis in infancy
Rinnov, M. R., Halling, A., Gerner, T., Ravn, N. H., Knudgaard, M. H., Trautner, S., Goorden, S. M. I., der Vlugt, K. G., Stet, F. S., Skov, L., et al. (2022) · Allergy · doi:10.1111/all.15518 · Cited by 85
Overview of Atopic Dermatitis in Different Ethnic Groups
Chiricozzi, A., Maurelli, M., Calabrese, L., Peris, K., & Girolomoni, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072701 · Cited by 84
Stratum corneum TARC level is a new indicator of lesional skin inflammation in atopic dermatitis
Morita, E., Takahashi, H., Niihara, H., Dekio, I., Sumikawa, Y., Murakami, Y., & Matsunaka, H. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.02361.x · Cited by 84
Clinical Efficacy of Blue Light Full Body Irradiation as Treatment Option for Severe Atopic Dermatitis
Becker, D., Langer, E., Seemann, M., Seemann, G., Fell, I., Saloga, J., Grabbe, S., & von Stebut, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020566 · Cited by 84
Tacrolimus Ointment 0.03% Is Safe and Effective for the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Patients: Results From a Randomized, Double-Blind, Vehicle-Controlled Study
Schachner, L. A., Lamerson, C. L., Sheehan, M. P., Boguniewicz, M., Mosser, J. L., Raimer, S., Shull, T., Jaracz, E., & for the US Tacrolimus Ointment Study Group (2005) · PEDIATRICS · doi:10.1542/peds.2004-2638 · Cited by 84
Skin pH–dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity
Hülpüsch, C., Tremmel, K., Hammel, G., Bhattacharyya, M., Tomassi, A. D., Nußbaumer, T., Neumann, A. U., Reiger, M., & Traidl‐Hoffmann, C. (2020) · Allergy · doi:10.1111/all.14461 · Cited by 83
Assessing the severity of atopic dermatitis in clinical trials and practice
Chopra, R., & Silverberg, J. I. (2018) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2018.05.012 · Cited by 83
Quality of Life of Parents of Children with Atopic Dermatitis
Marciniak, J., Reich, A., & Szepietowski, J. C. (2017) · Acta Dermato Venereologica · doi:10.2340/00015555-2633 · Cited by 82
Factors influencing quality of life in children with atopic dermatitis and their caregivers: a cross-sectional study
Xu, X., van Galen, L. S., Koh, M. J. A., Bajpai, R. C., Thng, S. T. G., Yew, Y. W., Ho, V. P. Y., Alagappan, U., Järbrink, K., & Car, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-51129-5 · Cited by 81
Quality of Life and Psychological Impact in Patients with Atopic Dermatitis
Talamonti, M., Galluzzo, M., Silvaggio, D., Lombardo, P., Tartaglia, C., & Bianchi, L. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061298 · Cited by 81
Difamilast ointment in adult patients with atopic dermatitis: A phase 3 randomized, double-blind, vehicle-controlled trial
Saeki, H., Ito, K., Yokota, D., & Tsubouchi, H. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.10.027 · Cited by 81
Stress in mothers of young children with eczema
Faught, J., Bierl, C., Barton, B., & Kemp, A. H. (2007) · Archives of Disease in Childhood · doi:10.1136/adc.2006.112268 · Cited by 81
MAS063DP is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children: A Multicenter, Randomized, Vehicle-Controlled Study
Boguniewicz, M., Zeichner, J., Eichenfield, L. F., Hebert, A. A., Jarratt, M., Lucky, A. W., & Paller, A. S. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.11.031 · Cited by 81
The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada
de Bruin-Weller, M. S., Gadkari, A., Auzière, S., Simpson, E. L., Puig, L., Barbarot, S., Girolomoni, G., Papp, K. A., Pink, A., Saba, G., et al. (2019) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16003 · Cited by 79
Assessment of health state utilities of controlled and uncontrolled psoriasis and atopic eczema: a population-based study
Schmitt, J. M., Meurer, M., Klon, M., & Frick, K. D. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08354.x · Cited by 78
Novel treatment of chronic severe hand dermatitis with bexarotene gel
Hanifin, J. M., Stevens, V., Sheth, P. B., & Breneman, D. (2004) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05729.x · Cited by 78
Self-citation
Validation of patient‐reported global severity of atopic dermatitis in adults
Vakharia, P. P., Chopra, R., Sacotte, R. M., Patel, N., Immaneni, S., White, T., Kantor, R. W., Hsu, D. Y., & Silverberg, J. I. (2017) · Allergy · doi:10.1111/all.13309 · Cited by 78
Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle‐controlled, multicenter clinical trial
Furue, M., Kitahara, Y., Akama, H., Hojo, S., Hayashi, N., Nakagawa, H., & The JAPANESE E6005 Study Investigators (2014) · The Journal of Dermatology · doi:10.1111/1346-8138.12534 · Cited by 77
Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice
Karuppagounder, V., Arumugam, S., Thandavarayan, R. A., Pitchaimani, V., Sreedhar, R., Afrin, R., Harima, M., Suzuki, H., Nomoto, M., Miyashita, S., et al. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.10.014 · Cited by 78
Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid
Travers, J. B., Kozman, A., Mousdicas, N., Saha, C., Landis, M. N., Al‐Hassani, M., Yao, W., Yao, Y., Hyatt, A.-M., Sheehan, M. P., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.09.052 · Cited by 78
Changes in Lesional and Non-lesional Skin Microbiome During Treatment of Atopic Dermatitis
Kwon, S., Choi, J., Shin, J. W., Huh, C., Park, K., Du, M., Yoon, S., & Na, J. (2018) · Acta Dermato Venereologica · doi:10.2340/00015555-3089 · Cited by 76
Qualidade de vida em pacientes pediátricos com dermatite atópica
Alvarenga, T. M. M., & Caldeira, A. P. (2009) · Jornal de Pediatria · doi:10.1590/s0021-75572009000500008 · Cited by 76
Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants
Kaufmann, R., Fölster‐Holst, R., Hoeger, P. H., Thaçi, D., Löffler, H., Staab, D., & Bräutigam, M. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.08.015 · Cited by 76
Thymic stromal lymphopoietin–activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis
Wu, W. H., Park, C. O., Oh, S. H., Kim, H. J., Kwon, Y. S., Bae, B. G., Noh, J. Y., & Lee, D. W. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.05.024 · Cited by 76
Extent and consequences of inadequate disease control among adults with a history of moderate to severe atopic dermatitis
Wei, W., Anderson, P. E., Gadkari, A. S., Blackburn, S., Moon, R., Piercy, J., Shinde, S., Gomez, J., & Ghorayeb, E. (2017) · The Journal of Dermatology · doi:10.1111/1346-8138.14116 · Cited by 75
Skin care interventions in infants for preventing eczema and food allergy
Kelleher, M. M., Phillips, R., Brown, S., Cro, S., Cornelius, V. R., Carlsen, K. C. L., Skjerven, H. O., Rehbinder, E. M., Lowe, A. J., Dissanayake, E., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013534.pub3 · Cited by 77
Frequency of contact allergens in pediatric patients with atopic dermatitis.
Herro, E. M., Matiz, C., Sullivan, K., Hamann, C. P., & Jacob, S. E. (2011) · PubMed Central · Cited by 75
Assessment of Intra- and Inter-Rater Reliability of Three Methods for Measuring Atopic Dermatitis Severity: EASI, Objective SCORAD, and IGA
Bożek, A., & Reich, A. (2017) · Dermatology · doi:10.1159/000472711 · Cited by 74
Phase 2 randomized clinical trial of astegolimab in patients with moderate to severe atopic dermatitis
Maurer, M., Cheung, D. S., Theess, W., Yang, X., Dolton, M. J., Guttman, A., Choy, D. F., Dash, A., Grimbaldeston, M. A., & Soong, W. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.08.015 · Cited by 74
Patient-Oriented SCORAD: A Self-Assessment Score in Atopic Dermatitis
Vourc’h, M., Barbarot, S., Taı̈eb, A., Diepgen, T. L., Ambonati, M., Durosier, V., Sibaud, V., & Stalder, J. F. (2009) · Dermatology · doi:10.1159/000193997 · Cited by 73
Baicalin ameliorates 2,4-dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice through modulating skin barrier function, gut microbiota and JAK/STAT pathway
Wang, L., Xian, Y., Loo, S. K. F., Ip, S., Yang, W., Chan, W. Y., Lin, Z., & Wu, J. C. Y. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2021.105538 · Cited by 73
Strategies for using topical corticosteroids in children and adults with eczema
Lax, S. J., Harvey, J., Axon, E., Howells, L., Santer, M., Ridd, M. J., Lawton, S., Langan, S., Roberts, A., Ahmed, A., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013356.pub2 · Cited by 72
Role of mild cleansing in the management of patient skin
Subramanyan, K. (2004) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2004.04s1003.x · Cited by 72
The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis
Mitsuishi, K., Nakamura, T., Sakata, Y., Yuyama, N., Arima, K., Sugita, Y., Suto, H., Izuhara, K., & Ogawa, H. (2005) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2005.02353.x · Cited by 72
Hair zinc levels and the efficacy of oral zinc supplementation in patients with atopic dermatitis
Kim, J., Yoo, S., Jeong, M., Ko, J., & Ro, Y. (2014) · Acta Dermato Venereologica · doi:10.2340/00015555-1772 · Cited by 71
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children
Simpson, E. L., Eichenfield, L. F., Alonso‐Llamazares, J., Draelos, Z. D., Ferris, L. K., Forman, S. B., Gooderham, M., González, M. E., Hebert, A. A., Kircik, L., et al. (2024) · JAMA Dermatology · doi:10.1001/jamadermatol.2024.3121 · Cited by 71
Food Allergy in Infants With Atopic Dermatitis: Limitations of Food-Specific IgE Measurements
Spergel, J. M., Boguniewicz, M., Schneider, L. C., Hanifin, J. M., Paller, A. S., & Eichenfield, L. F. (2015) · PEDIATRICS · doi:10.1542/peds.2015-1444 · Cited by 71
Self-citation
Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial
Saeki, H., Baba, N., Ito, K., Yokota, D., & Tsubouchi, H. (2021) · British Journal of Dermatology · doi:10.1111/bjd.20655 · Cited by 71
Interventions to reduce Staphylococcus aureus in the management of eczema
George, S. M., Karanovic, S., Harrison, D. A., Rani, A., Birnie, A. J., Bath-Hextall, F. J., Ravenscroft, J., & Williams, H. C. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003871.pub3 · Cited by 70
Topical ozone therapy restores microbiome diversity in atopic dermatitis
Zeng, J., Dou, J., Gao, L., Xiang, Y., Huang, J., Ding, S., Chen, J., Zeng, Q., Luo, Z., Tan, W., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106191 · Cited by 78
What are the best endpoints for Eczema Area and Severity Index and Scoring Atopic Dermatitis in clinical practice? A prospective observational study*
Silverberg, J. I., Lei, D. K., Yousaf, M., Janmohamed, S. R., Vakharia, P. P., Chopra, R., Chavda, R., Gabriel, S., Patel, K. R., Singam, V., et al. (2020) · British Journal of Dermatology · doi:10.1111/bjd.19457 · Cited by 69
Relationship between EASI and SCORAD severity assessments for atopic dermatitis
Chopra, R., Vakharia, P. P., Sacotte, R. M., Patel, N., Immaneni, S., White, T., Kantor, R. W., Hsu, D. Y., & Silverberg, J. I. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.04.052 · Cited by 69
Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study
Oosterhaven, J. A. F., Voorberg, A. N., Romeijn, G. L. E., de Bruin-Weller, M. S., & Schuttelaar, M. L. A. (2019) · The Journal of Dermatology · doi:10.1111/1346-8138.14982 · Cited by 69
Genetic Variants in Interferon Regulatory Factor 2 (IRF2) Are Associated with Atopic Dermatitis and Eczema Herpeticum
Gao, P.-S., Leung, D. Y. M., Rafaels, N. M., Boguniewicz, M., Hand, T. A., Gao, L., Hata, T. R., Schneider, L. C., Hanifin, J. M., Beaty, T. H., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.374 · Cited by 68
Self-citation

Authors: Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., & Evaluator Group, T. E.
Affiliations: Oregon Health & Science University (US)
Novartis (Switzerland) (CH)
Shiga University of Medical Science (JP)
Corresponding author: Hanifin, J. M.
ORCID: Hanifin, J. M.
Venue: Experimental Dermatology
Publisher: Wiley
Published: 2001-02
Volume: 10
Issue: 1
Pages: 11-18
ISSN: 0906-6705 (ISSN-L)
1600-0625
DOI: 10.1034/j.1600-0625.2001.100102.x
OpenAlex: W2117359358
Cited by: 1,200
References: 17
Citations by year: 2026: 69 · 2025: 85 · 2024: 92 · 2023: 101 · 2022: 84 · 2021: 98 · 2020: 82 · 2019: 63 · 2018: 47 · 2017: 46 · 2016: 53 · 2015: 28 · 2014: 43 · 2013: 23 · 2012: 21
FWCI: 20.78
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2713 d)
Locations: Experimental Dermatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Keywords: Eczema Area and Severity Index, atopic dermatitis, inter-rater reliability, intra-rater reliability, disease severity assessment, disease extent assessment, clinical trial outcome measures
MeSH terms: Adolescent, Adult, Child, Child, Preschool, Dermatitis, Atopic, Dermatology, Eczema, Humans, Infant, Infant, Newborn, Severity of Illness Index, Reproducibility of Results, Cohort Studies, Observer Variation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks